// App-Quantinova.ai

: Angiotensin 2 type 2 receptor blockade is a novel target for murine osteoarthritis pain

Researchers

Presenter

  • I.S. von Loga

Principal Investigators

  • J. Miotla-Zarebska

  • E. Wyeth

  • T. McCarthy

  • C. Bountra

  • T.L. Vincent

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • Molecule 2 Med., Stanton Harcourt, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Angiotensinogen

  • Nerve Growth Factor

  • Solute Carrier Family 33 Member 1

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved